Tetsunori Seki

1.3k total citations
26 papers, 1.1k citations indexed

About

Tetsunori Seki is a scholar working on Molecular Biology, Surgery and Immunology. According to data from OpenAlex, Tetsunori Seki has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Surgery and 7 papers in Immunology. Recurrent topics in Tetsunori Seki's work include Tissue Engineering and Regenerative Medicine (5 papers), Cardiac Fibrosis and Remodeling (5 papers) and Mesenchymal stem cell research (4 papers). Tetsunori Seki is often cited by papers focused on Tissue Engineering and Regenerative Medicine (5 papers), Cardiac Fibrosis and Remodeling (5 papers) and Mesenchymal stem cell research (4 papers). Tetsunori Seki collaborates with scholars based in United States, Australia and Austria. Tetsunori Seki's co-authors include Silviu Itescu, Jack Silver, Michael Schuster, Timothy P. Martens, Tetsuya Moriuchi, Alfred Kocher, Hugo Sondermeijer, Piotr Witkowski, Hsiu‐Ching Chang and Robert Winchester and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Tetsunori Seki

26 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tetsunori Seki United States 19 524 282 261 225 119 26 1.1k
Christopher Siatskas Australia 20 482 0.9× 343 1.2× 213 0.8× 407 1.8× 29 0.2× 39 1.3k
Hironobu Fujiwara Japan 20 754 1.4× 147 0.5× 176 0.7× 82 0.4× 105 0.9× 38 1.9k
Shu Uin Gan Singapore 18 395 0.8× 182 0.6× 306 1.2× 271 1.2× 86 0.7× 44 980
Shoshan Knaän‐Shanzer Netherlands 22 690 1.3× 196 0.7× 343 1.3× 317 1.4× 76 0.6× 34 1.3k
Mary Shannon Byers United States 12 842 1.6× 298 1.1× 148 0.6× 74 0.3× 33 0.3× 13 1.5k
John A. Muraski United States 15 907 1.7× 102 0.4× 476 1.8× 224 1.0× 169 1.4× 18 1.5k
Vimal Kishor Singh India 16 633 1.2× 65 0.2× 288 1.1× 306 1.4× 94 0.8× 29 1.2k
Dorina Veliceasa United States 21 775 1.5× 284 1.0× 88 0.3× 146 0.6× 62 0.5× 28 1.4k
Yatin Patel United Kingdom 13 495 0.9× 90 0.3× 132 0.5× 75 0.3× 106 0.9× 23 981
Sophia K. Khaldoyanidi United States 24 788 1.5× 509 1.8× 116 0.4× 223 1.0× 68 0.6× 50 1.7k

Countries citing papers authored by Tetsunori Seki

Since Specialization
Citations

This map shows the geographic impact of Tetsunori Seki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsunori Seki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsunori Seki more than expected).

Fields of papers citing papers by Tetsunori Seki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsunori Seki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsunori Seki. The network helps show where Tetsunori Seki may publish in the future.

Co-authorship network of co-authors of Tetsunori Seki

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsunori Seki. A scholar is included among the top collaborators of Tetsunori Seki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsunori Seki. Tetsunori Seki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sondermeijer, Hugo, Piotr Witkowski, Tetsunori Seki, et al.. (2017). RGDfK-Peptide Modified Alginate Scaffold for Cell Transplantation and Cardiac Neovascularization. Tissue Engineering Part A. 24(9-10). 740–751. 21 indexed citations
2.
3.
Sondermeijer, Hugo, Piotr Witkowski, David Woodland, et al.. (2016). Optimization of alginate purification using polyvinylidene difluoride membrane filtration: Effects on immunogenicity and biocompatibility of three-dimensional alginate scaffolds. Journal of Biomaterials Applications. 31(4). 510–520. 26 indexed citations
4.
Bonaros, Nikolaos, Hugo Sondermeijer, Dominik Wiedemann, et al.. (2011). Downregulation of the CXC chemokine receptor 4/stromal cell–derived factor 1 pathway enhances myocardial neovascularization, cardiomyocyte survival, and functional recovery after myocardial infarction. Journal of Thoracic and Cardiovascular Surgery. 142(3). 687–696.e2. 5 indexed citations
5.
See, Fiona, Tetsunori Seki, Peter J. Psaltis, et al.. (2010). Therapeutic effects of human STRO‐3‐selected mesenchymal precursor cells and their soluble factors in experimental myocardial ischemia. Journal of Cellular and Molecular Medicine. 15(10). 2117–2129. 48 indexed citations
6.
Bonaros, Nikolaos, Michael Schuster, Tetsunori Seki, et al.. (2008). CCR3- and CXCR4-mediated interactions regulate migration of CD34+ human bone marrow progenitors to ischemic myocardium and subsequent tissue repair. Journal of Thoracic and Cardiovascular Surgery. 136(4). 1044–1053. 18 indexed citations
7.
Witkowski, Piotr, Tetsunori Seki, Guosheng Xiang, et al.. (2007). A DNA Enzyme Against Plasminogen Activator Inhibitor- type 1 (PAI-1) Limits Neointima Formation After Angioplasty in an Obese Diabetic Rodent Model. Journal of Cardiovascular Pharmacology. 50(6). 633–640. 7 indexed citations
8.
Colovai, Adriana I., Su Wang, Hana Lin, et al.. (2007). Expression of inhibitory receptor ILT3 on neoplastic B cells is associated with lymphoid tissue involvement in chronic lymphocytic leukemia. Cytometry Part B Clinical Cytometry. 72B(5). 354–362. 47 indexed citations
9.
Martens, Timothy P., Fiona See, Michael Schuster, et al.. (2006). Mesenchymal lineage precursor cells induce vascular network formation in ischemic myocardium. Nature Clinical Practice Cardiovascular Medicine. 3(S1). S18–S22. 81 indexed citations
10.
Kim‐Schulze, Seunghee, Tetsunori Seki, George Vlad, et al.. (2005). Regulation of ILT3 Gene Expression by Processing of Precursor Transcripts in Human Endothelial Cells. American Journal of Transplantation. 6(1). 76–82. 38 indexed citations
11.
Xiang, Guosheng, et al.. (2005). Downregulated Expression of Plasminogen Activator Inhibitor-1 Augments Myocardial Neovascularization and Reduces Cardiomyocyte Apoptosis After Acute Myocardial Infarction. Journal of the American College of Cardiology. 46(3). 536–541. 29 indexed citations
12.
Xiang, Guosheng, Tetsunori Seki, Michael Schuster, et al.. (2005). Catalytic Degradation of Vitamin D Up-regulated Protein 1 mRNA Enhances Cardiomyocyte Survival and Prevents Left Ventricular Remodeling after Myocardial Ischemia. Journal of Biological Chemistry. 280(47). 39394–39402. 69 indexed citations
13.
Xiang, Guosheng, Michael Schuster, Tetsunori Seki, et al.. (2004). Down-regulation of Plasminogen Activator Inhibitor 1 Expression Promotes Myocardial Neovascularization by Bone Marrow Progenitors. The Journal of Experimental Medicine. 200(12). 1657–1666. 30 indexed citations
14.
Schuster, Michael, Alfred Kocher, Tetsunori Seki, et al.. (2004). Myocardial neovascularization by bone marrow angioblasts results in cardiomyocyte regeneration. American Journal of Physiology-Heart and Circulatory Physiology. 287(2). H525–H532. 134 indexed citations
15.
Seki, Tetsunori, et al.. (1998). Use of a differential subtraction method to identify genes that characterize the phenotype of cultured rheumatoid arthritis synoviocytes. Arthritis & Rheumatism. 41(8). 1356–1364. 64 indexed citations
16.
Mongini, Patricia K. A., et al.. (1992). Differential effects of cyclosporin A on diverse B cell activation phenomena triggered by crosslinking of membrane IgM. Cellular Immunology. 140(2). 478–494. 3 indexed citations
17.
Seki, Tetsunori. (1989). Identification of multiple isoforms of the low-affinity human IgG Fc receptor. Immunogenetics. 30(1). 5–12. 34 indexed citations
18.
Navarrete, Cristina, et al.. (1989). DNA sequence analysis of the HLA-DRw12 allele. Human Immunology. 25(1). 51–58. 30 indexed citations
19.
Gordon, Jon W., Pilar Garin Chesa, Hiroyuki Nishimura, et al.. (1987). Regulation of Thy-1 gene expression in transgenic mice. Cell. 50(3). 445–452. 115 indexed citations
20.
Seki, Tetsunori, Hsiu‐Ching Chang, Tetsuya Moriuchi, et al.. (1985). A Hydrophobic Transmembrane Segment at the Carboxyl Terminus of thy-1. Science. 227(4687). 649–651. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher Siatskas Breakdown of academic impact, for papers by Hironobu Fujiwara Breakdown of academic impact, for papers by Shu Uin Gan Breakdown of academic impact, for papers by Shoshan Knaän‐Shanzer Breakdown of academic impact, for papers by Mary Shannon Byers Breakdown of academic impact, for papers by John A. Muraski Breakdown of academic impact, for papers by Vimal Kishor Singh Breakdown of academic impact, for papers by Dorina Veliceasa Breakdown of academic impact, for papers by Yatin Patel Breakdown of academic impact, for papers by Sophia K. Khaldoyanidi
Rankless by CCL
2026